Can Erasca be biotech’s next big thing? We’ll see What to know about the company aiming to outdo RevMed in cancer By Adam FeuersteinApril 23, 2026 Senior Writer, Biotech

https://www.statnews.com/2026/04/23/erasca-oncology-cancer-drug-stock/